Therapeutic HIV-1 Tat vaccination promotes durable immune reconstitution and reservoir reduction in ART-treated adults with clade C infection: a 12-year follow-up study.
Saved in:
| Title: | Therapeutic HIV-1 Tat vaccination promotes durable immune reconstitution and reservoir reduction in ART-treated adults with clade C infection: a 12-year follow-up study. |
|---|---|
| Authors: | Picconi O; National HIV/AIDS Research Center, Istituto Superiore di Sanità, Rome, Italy., Sgadari C; National HIV/AIDS Research Center, Istituto Superiore di Sanità, Rome, Italy., Tripiciano A; National HIV/AIDS Research Center, Istituto Superiore di Sanità, Rome, Italy., Moretti S; National HIV/AIDS Research Center, Istituto Superiore di Sanità, Rome, Italy., Maggiorella MT; National HIV/AIDS Research Center, Istituto Superiore di Sanità, Rome, Italy., Francavilla V; National HIV/AIDS Research Center, Istituto Superiore di Sanità, Rome, Italy., Casabianca A; Department of Biomolecular Science, University of Urbino, Urbino, Italy., Orlandi C; Department of Biomolecular Science, University of Urbino, Urbino, Italy., Belli R; National HIV/AIDS Research Center, Istituto Superiore di Sanità, Rome, Italy., Palladino C; National HIV/AIDS Research Center, Istituto Superiore di Sanità, Rome, Italy., Campagna M; National HIV/AIDS Research Center, Istituto Superiore di Sanità, Rome, Italy., Mancini F; National HIV/AIDS Research Center, Istituto Superiore di Sanità, Rome, Italy., Sernicola L; National HIV/AIDS Research Center, Istituto Superiore di Sanità, Rome, Italy., Pavone Cossut MR; National HIV/AIDS Research Center, Istituto Superiore di Sanità, Rome, Italy., Pimpinelli F; Laboratory of Microbiology and Virology, San Gallicano Dermatological Institute, IRCCS, Rome, Italy., Magnani M; Department of Biomolecular Science, University of Urbino, Urbino, Italy., Ensoli F; Laboratory of Clinical Pathology and Microbiology, San Gallicano Dermatological Institute, IRCCS, Rome, Italy., Mathebula M; Mecru Clinical Research Unit (MeCRU), Sefako Makgatho Health Sciences University (SMU), Gauteng, South Africa., Cafaro A; National HIV/AIDS Research Center, Istituto Superiore di Sanità, Rome, Italy., Monini P; National HIV/AIDS Research Center, Istituto Superiore di Sanità, Rome, Italy., Nchabeleng M; Mecru Clinical Research Unit (MeCRU), Sefako Makgatho Health Sciences University (SMU), Gauteng, South Africa.; National Health Service, Dr George Mukhari Microbiology Laboratory, Pretoria, South Africa., Ensoli B; National HIV/AIDS Research Center, Istituto Superiore di Sanità, Rome, Italy. |
| Source: | Frontiers in immunology [Front Immunol] 2026 Apr 10; Vol. 17, pp. 1769223. Date of Electronic Publication: 2026 Apr 10 (Print Publication: 2026). |
| Publication Type: | Journal Article; Randomized Controlled Trial; Clinical Trial, Phase II |
| Journal Info: | Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101560960 Publication Model: eCollection Cited Medium: Internet ISSN: 1664-3224 (Electronic) Linking ISSN: 16643224 NLM ISO Abbreviation: Front Immunol Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| FullText | Links: – Type: pdflink Text: Availability: 1 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 42039169 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Therapeutic HIV-1 Tat vaccination promotes durable immune reconstitution and reservoir reduction in ART-treated adults with clade C infection: a 12-year follow-up study. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Picconi+O%22">Picconi O</searchLink>; National HIV/AIDS Research Center, Istituto Superiore di Sanità, Rome, Italy.<br /><searchLink fieldCode="AU" term="%22Sgadari+C%22">Sgadari C</searchLink>; National HIV/AIDS Research Center, Istituto Superiore di Sanità, Rome, Italy.<br /><searchLink fieldCode="AU" term="%22Tripiciano+A%22">Tripiciano A</searchLink>; National HIV/AIDS Research Center, Istituto Superiore di Sanità, Rome, Italy.<br /><searchLink fieldCode="AU" term="%22Moretti+S%22">Moretti S</searchLink>; National HIV/AIDS Research Center, Istituto Superiore di Sanità, Rome, Italy.<br /><searchLink fieldCode="AU" term="%22Maggiorella+MT%22">Maggiorella MT</searchLink>; National HIV/AIDS Research Center, Istituto Superiore di Sanità, Rome, Italy.<br /><searchLink fieldCode="AU" term="%22Francavilla+V%22">Francavilla V</searchLink>; National HIV/AIDS Research Center, Istituto Superiore di Sanità, Rome, Italy.<br /><searchLink fieldCode="AU" term="%22Casabianca+A%22">Casabianca A</searchLink>; Department of Biomolecular Science, University of Urbino, Urbino, Italy.<br /><searchLink fieldCode="AU" term="%22Orlandi+C%22">Orlandi C</searchLink>; Department of Biomolecular Science, University of Urbino, Urbino, Italy.<br /><searchLink fieldCode="AU" term="%22Belli+R%22">Belli R</searchLink>; National HIV/AIDS Research Center, Istituto Superiore di Sanità, Rome, Italy.<br /><searchLink fieldCode="AU" term="%22Palladino+C%22">Palladino C</searchLink>; National HIV/AIDS Research Center, Istituto Superiore di Sanità, Rome, Italy.<br /><searchLink fieldCode="AU" term="%22Campagna+M%22">Campagna M</searchLink>; National HIV/AIDS Research Center, Istituto Superiore di Sanità, Rome, Italy.<br /><searchLink fieldCode="AU" term="%22Mancini+F%22">Mancini F</searchLink>; National HIV/AIDS Research Center, Istituto Superiore di Sanità, Rome, Italy.<br /><searchLink fieldCode="AU" term="%22Sernicola+L%22">Sernicola L</searchLink>; National HIV/AIDS Research Center, Istituto Superiore di Sanità, Rome, Italy.<br /><searchLink fieldCode="AU" term="%22Pavone+Cossut+MR%22">Pavone Cossut MR</searchLink>; National HIV/AIDS Research Center, Istituto Superiore di Sanità, Rome, Italy.<br /><searchLink fieldCode="AU" term="%22Pimpinelli+F%22">Pimpinelli F</searchLink>; Laboratory of Microbiology and Virology, San Gallicano Dermatological Institute, IRCCS, Rome, Italy.<br /><searchLink fieldCode="AU" term="%22Magnani+M%22">Magnani M</searchLink>; Department of Biomolecular Science, University of Urbino, Urbino, Italy.<br /><searchLink fieldCode="AU" term="%22Ensoli+F%22">Ensoli F</searchLink>; Laboratory of Clinical Pathology and Microbiology, San Gallicano Dermatological Institute, IRCCS, Rome, Italy.<br /><searchLink fieldCode="AU" term="%22Mathebula+M%22">Mathebula M</searchLink>; Mecru Clinical Research Unit (MeCRU), Sefako Makgatho Health Sciences University (SMU), Gauteng, South Africa.<br /><searchLink fieldCode="AU" term="%22Cafaro+A%22">Cafaro A</searchLink>; National HIV/AIDS Research Center, Istituto Superiore di Sanità, Rome, Italy.<br /><searchLink fieldCode="AU" term="%22Monini+P%22">Monini P</searchLink>; National HIV/AIDS Research Center, Istituto Superiore di Sanità, Rome, Italy.<br /><searchLink fieldCode="AU" term="%22Nchabeleng+M%22">Nchabeleng M</searchLink>; Mecru Clinical Research Unit (MeCRU), Sefako Makgatho Health Sciences University (SMU), Gauteng, South Africa.; National Health Service, Dr George Mukhari Microbiology Laboratory, Pretoria, South Africa.<br /><searchLink fieldCode="AU" term="%22Ensoli+B%22">Ensoli B</searchLink>; National HIV/AIDS Research Center, Istituto Superiore di Sanità, Rome, Italy. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22101560960%22">Frontiers in immunology</searchLink> [Front Immunol] 2026 Apr 10; Vol. 17, pp. 1769223. <i>Date of Electronic Publication: </i>2026 Apr 10 (<i>Print Publication: </i>2026). – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article; Randomized Controlled Trial; Clinical Trial, Phase II – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Frontiers+Research+Foundation]%22">Frontiers Research Foundation] </searchLink><i>Country of Publication: </i>Switzerland <i>NLM ID: </i>101560960 <i>Publication Model: </i>eCollection <i>Cited Medium: </i>Internet <i>ISSN: </i>1664-3224 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2216643224%22">16643224 </searchLink><i>NLM ISO Abbreviation: </i>Front Immunol <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=42039169 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.3389/fimmu.2026.1769223 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 1769223 Titles: – TitleFull: Therapeutic HIV-1 Tat vaccination promotes durable immune reconstitution and reservoir reduction in ART-treated adults with clade C infection: a 12-year follow-up study. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Picconi O – PersonEntity: Name: NameFull: Sgadari C – PersonEntity: Name: NameFull: Tripiciano A – PersonEntity: Name: NameFull: Moretti S – PersonEntity: Name: NameFull: Maggiorella MT – PersonEntity: Name: NameFull: Francavilla V – PersonEntity: Name: NameFull: Casabianca A – PersonEntity: Name: NameFull: Orlandi C – PersonEntity: Name: NameFull: Belli R – PersonEntity: Name: NameFull: Palladino C – PersonEntity: Name: NameFull: Campagna M – PersonEntity: Name: NameFull: Mancini F – PersonEntity: Name: NameFull: Sernicola L – PersonEntity: Name: NameFull: Pavone Cossut MR – PersonEntity: Name: NameFull: Pimpinelli F – PersonEntity: Name: NameFull: Magnani M – PersonEntity: Name: NameFull: Ensoli F – PersonEntity: Name: NameFull: Mathebula M – PersonEntity: Name: NameFull: Cafaro A – PersonEntity: Name: NameFull: Monini P – PersonEntity: Name: NameFull: Nchabeleng M – PersonEntity: Name: NameFull: Ensoli B IsPartOfRelationships: – BibEntity: Dates: – D: 10 M: 04 Text: 2026 Apr 10 Type: published Y: 2026 Identifiers: – Type: issn-electronic Value: 1664-3224 Numbering: – Type: volume Value: 17 Titles: – TitleFull: Frontiers in immunology Type: main |
| ResultId | 1 |
